CPT® Code 84203

1. Indications

The CPT® Code 84203 is indicated for use in the following scenarios:

• Iron Deficiency Anemia - The test is performed to evaluate patients suspected of having iron deficiency anemia, which is characterized by low iron levels leading to increased protoporphyrin in red blood cells.
• Erythropoietic Protoporphyria (EPP) - This test is utilized in the diagnosis of EPP, a genetic disorder that results in the accumulation of protoporphyrin in the body.
• Lead Exposure - The test is indicated for individuals who may have been exposed to lead, as lead toxicity can disrupt heme synthesis and lead to elevated protoporphyrin levels.
• Porphyrias - It is also indicated for assessing porphyrias caused by heavy metals, solvents, and certain medications, which can result in increased protoporphyrin levels.

2. Procedure

The procedure for performing the test associated with CPT® Code 84203 involves several key steps:

• Sample Collection - A blood sample is drawn from the patient, typically from a vein in the arm, using standard venipuncture techniques. The collected blood is then placed in a suitable container for laboratory analysis.
• Laboratory Analysis - The blood sample is processed in a laboratory where the levels of protoporphyrin in the red blood cells are measured. This may involve specific biochemical assays designed to quantify protoporphyrin concentrations accurately.
• Result Interpretation - Once the analysis is complete, the results are interpreted by a qualified healthcare professional. Elevated levels of protoporphyrin are assessed in the context of the patient's clinical history and other laboratory findings to determine the underlying cause.

3. Post-Procedure

After the procedure associated with CPT® Code 84203, there are generally no specific post-procedure care requirements for the patient, as the blood draw is a routine procedure. Patients may experience minor discomfort or bruising at the site of the venipuncture, which typically resolves quickly. The healthcare provider will review the test results with the patient, discussing any necessary follow-up actions or additional testing that may be required based on the findings. It is important for patients to report any unusual symptoms or concerns following the blood draw to their healthcare provider.